In addition to the collaborative development of products for quality control in Regenerative Medicine, Epiontis currently develops assays for a range of immune cells with the goal to provide a set of tools that will allow a comprehensive analysis of the status of a patient's immune system. The most advanced product for immune monitoring is the EpiTest Treg assay for monitoring of regulatory T cells.